Skip to main content
HR 2855 111th Congress House Health Drug trafficking and controlled substances Drug, alcohol, tobacco use Emergency medical services and trauma care Health information and medical records Health personnel Health programs administration and funding Health promotion and preventive care Medical education Medical research Medical tests and diagnostic methods Research administration and funding

Drug Overdose Reduction Act

Introduced: June 12, 2009 See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 15, 2009
Referred to the Subcommittee on Health.
Jun 12, 2009
Referred to the House Committee on Energy and Commerce.
Jun 12, 2009
Introduced in House
 Plain-English summary Congressional Research Service

Drug Overdose Reduction Act - Requires the Director of the Centers for Disease Control and Prevention (CDC) to: (1) award grants or enter into cooperative agreements to enable eligible entities to reduce deaths occurring from drug overdoses; and (2) give priority to public health agencies or community-based organizations that have expertise in preventing deaths occurring from overdoses in high risk populations.

Conditions receipt of a grant or agreement on an entity agreeing to use the grant or agreement for: (1) purchasing and distributing drug overdose reversal agents; (2) training first responders, law enforcement and corrections officials, and other individuals in a position to respond to an overdose on the effective response; (3) implementing programs to provide overdose prevention, recognition, treatment, or response to individuals in need; and (4) evaluating, expanding, or replicating such programs.

Requires the Director to: (1) compile and publish data, annually, on fatal and nonfatal drug overdoses for the preceding year; (2) award grants to state, local, or tribal governments to improve drug overdose surveillance capabilities; and (3) develop and submit to Congress a plan to reduce the number of deaths occurring from overdoses.

Requires the Director of the National Institute on Drug Abuse (NIDA) to: (1) prioritize and conduct or support research on drug overdose and overdose prevention; and (2) support research on dosage forms of naloxone for the prehospital treatment of unintentional drug overdose.

What's happening now June 15, 2009

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2